Principal Investigator
Peter Hosein
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20250443
Clinical Trial Summary
Expanded Access Protocol for ELI-002 7P Immunotherapy as Treatment for Patients with Kirsten Rat Sarcoma (KRAS)/Neuroblastoma RAS viral oncogene homolog (NRAS) Mutated Pancreatic Ductal Adenocarcinoma (PDAC)
Phase
N/A
Funding Agency/Sponsor
Industrial
Disease
Stomach and Esophageal Cancer
Contact Information
Phone Number
305-243-2647